NovoCure Competitors and Similar CompaniesClear all
NovoCure's competitors and similar companies include Lyell, Silverback Therapeutics and Legend Biotech.
 NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors. |  Silverback Therapeutics Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases. |  Legend Biotech Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
| ||
Founding Date | Founding Date 2000 | Founding Date 2018 | Founding Date 2016 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Seattle, US HQ | Locations Somerset, US HQ Ghent, BE Nanjing, CN Hong Kong, HK Dublin, IE Piscataway, US | |
Employees | Employees 1,488 | Employees 188 | Employees 9067% increase | Employees 2,90012% increase |
Valuation ($) | Valuation ($) 1.8 b | Valuation ($) 243.3 m | Valuation ($) 550.4 m | Valuation ($) 8.4 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $655.4m (FY, 2025) | Revenue (est.) $36k (FY, 2025) | Revenue (est.) $1.3m (FY, 2022) | Revenue (est.) $1b (FY, 2025) |
Cost of goods | Cost of goods $166.9m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $408.1m (FY, 2025) |
Gross profit | Gross profit $488.5m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $620.8m (FY, 2025) |
Net income | Net income ($136.2m) (FY, 2025) | Net income ($274.4m) (FY, 2025) | Net income ($34.7m) (FY, 2022) | Net income ($296.8m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 211m | Total funding raised $ 150.5m |
For sources of this data, please see the company profile
View Company Profiles
Lyell
HQ
South San Francisco, US
Employees
188
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View companySilverback Therapeutics
HQ
Seattle, US
Employees
90
Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.
View companyLegend Biotech
HQ
Somerset, US
Employees
2,900↑ 12% increase
Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
View company